Press release
Future of United States Inherited Retinal Diseases Market | Advances in Gene Therapy | Major Companies likes - Novartis AG, REGENXBIO Inc, Gensight Biologics, ProQR Therapeutics, Bionic Vision Technologies
Inherited Retinal Disease Market
The Inherited Retinal Disease Market, as examined by DataM Intelligence, provides a thorough industry overview enriched with detailed insights, historical data, and essential statistics. The report extensively explores market dynamics and competitive landscapes, featuring profiles of leading companies, their product offerings, pricing strategies, financials, growth plans, and geographic footprint.
Unlock exclusive insights with our detailed sample report (Corporate Email ID to get priority access) @ https://datamintelligence.com/download-sample/inherited-retinal-disease-market?ca
Inherited Retinal Diseases are a group of genetic disorders that cause progressive vision loss due to retinal cell degeneration, often leading to blindness, with treatments focusing on gene therapy, low-vision aids, and supportive care.
Opus Genetics showcased new clinical gene therapy programs for IRDs-including Leber congenital amaurosis-at major international conferences in September, highlighting its ongoing research pipeline.
Prominent Industry players in the Inherited Retinal Disease Market
The prominent players in Inherited Retinal Disease Market research report are: Novartis AG, REGENXBIO Inc, Gensight Biologics, ProQR Therapeutics, Bionic Vision Technologies, ReNeuron Group plc, Ocugen Inc, PIXIUM VISION, Carl Zeiss Meditech AG, Spark Therapeutics, Inc.
The companies are primarily focusing on strategies such as new product launches to penetrate the fastest-growing emerging markets across the world.
Buy Now & Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?ca
Industry News
The National Institute for Health and Care Excellence (NICE) in the UK approved idebenone (Raxone) in September 2025 for treating specific IRDs, marking a significant product and reimbursement announcement.
Active clinical trials include over 30 therapies under investigation for diverse inherited retinal diseases such as Leber congenital amaurosis and retinitis pigmentosa.
Researchers announced new virus-like particles for more efficient gene editing, non-invasive transpalpebral electrical stimulation (TES) studies showing promise, and a new gene (UBAP1L) linked to macular IRDs, thereby advancing diagnostic capabilities.
The AI-powered Eye2Gene platform is seeing broader adoption, using multimodal imaging for rapid, accurate IRD diagnoses as of July-September 2025.
The IRD market is witnessing ongoing investments and partnerships aimed at mutation-specific product development and clinical trial expansion, with North America and Europe leading in clinical adoption and treatment penetration.
Prevalence is increasing due to improved genetic testing and awareness, and market growth is further supported by expanded early intervention strategies and hospital infrastructure upgrades globally.
Speak to Our Senior Analyst and Get Customization in the report as per your requirements @ https://datamintelligence.com/customize/inherited-retinal-disease-market?ca
Market Segments
➥ By Disease Type: Retinitis Pigmentosa (RP), Choroideremia, Stargardt Disease, Cone-rod Dystrophy (CRD), Leber Congenital Amaurosis, Others
➥ By Treatment Type: Gene Therapy, Symptomatic Treatment
➥ By End-User: Hospitals and Clinics, Ambulatory Surgical Centers, Others
The Inherited Retinal Disease Market industry is undergoing swift expansion, fueled by breakthroughs in medical technology, growing demand for cutting-edge therapies, and an increasing emphasis on patient-centric care. As the sector advances, in-depth market analysis is essential to track evolving trends, regulatory developments, and new opportunities.
Regions Covered:
The global Inherited Retinal Disease Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.
☞ North America - US, Canada, Mexico
☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe
☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific
☞ South America- Brazil, Argentina, Colombia, Rest of South America
☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel
FAQs:
✒ What is driving the growth of the Inherited Retinal Disease Market?
✒ Who are the prominent players in the Inherited Retinal Disease Market?
✒ How is the regulatory landscape affecting the Inherited Retinal Disease Market?
✒ What regions are expected to see the highest growth?
✒ What are the key challenges faced by the Inherited Retinal Disease Market?
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights-all in one place.
✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ Technology Road Map Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring
✅ Consumer Behavior & Demand Analysis
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Future of United States Inherited Retinal Diseases Market | Advances in Gene Therapy | Major Companies likes - Novartis AG, REGENXBIO Inc, Gensight Biologics, ProQR Therapeutics, Bionic Vision Technologies here
News-ID: 4203433 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
United States Vein Illumination Devices Industry Intelligence Research 2025: Inn …
Vein Illumination Devices Market reached US$ 458.74 million in 2024 and is expected to reach US$ 3,186.11 million by 2033, growing at a CAGR of 21.3% during the forecast period 2025-2033.
DataM Intelligence unveils its latest report on the "Vein Illumination Devices Market Size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume, CAGR forecasts, and…
United States In-wheel Motor Industry Sector Forecast 2025-2032 | BEV, HEV, PHEV …
DataM Intelligence unveils its latest report on the "In-wheel Motor Market Size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume, CAGR forecasts, and emerging opportunities that can guide businesses in seizing growth potential and crafting winning strategies. Packed with data-driven insights on current developments and future trends, this report is essential for companies aiming…
United States Digital Identity Solutions Industry Insights 2025: Growth, Top Pla …
Digital Identity Solutions Market surged to US$42.45 billion in 2024 from US$35.50 billion in 2023 and is projected to skyrocket to US$189.92 billion by 2033, expanding at a robust CAGR of 20.45% during 2025-2033, fueled by the rising demand for secure and seamless digital authentication worldwide.
DataM Intelligence unveils its latest report on the "Digital Identity Solutions Market Size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape,…
United States Electric Vehicle (EV) Thermal Management Systems Industry Sector O …
Electric Vehicle Thermal Management Systems Market was valued at USD 3.2 billion in 2022 and is projected to surge to USD 14.4 billion by 2031, growing at a CAGR of 20.6% from 2024 to 2031. The market's rapid expansion is fueled by the global shift toward electric vehicles, positioning thermal management systems as a key component in the EV ecosystem.
DataM Intelligence unveils its latest report on the "Electric Vehicle Thermal…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
